UOC
PRTA icon

UBS O'Connor’s Prothena Corp PRTA Stock Holding History

UBS O'Connor’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-30,000
Closed -$1.05M – 479
2016
Q2 		$1.05M Buy
30,000
+22,237
+286% +$969K 0.02% 297
2016
Q1 		$320K Buy
+7,763
New +$304K 0.01% 382
2014
Q4 		– Sell
-35,000
Closed -$776K – 701
2014
Q3 		$776K Sell
35,000
-58,800
-63% -$1.25M 0.01% 365
2014
Q2 		$2.12M Buy
+93,800
New +$2.35M 0.01% 273

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS O'Connor's PRTA Position: Q3 2016 in Review

UBS O'Connor sold out of Prothena Corp (PRTA) in Q3 2016, closing a stake of 30,000 shares — an estimated $1.05M sold.

UBS O'Connor first reported a position in PRTA in Q2 2014 and held it in 4 quarters. The position peaked at $2.12M in Q2 2014. 146 funds tracked by Wall St. Rank hold PRTA as of Q3 2016.

  • UBS O'Connor reported no remaining Prothena Corp position as of Q3 2016 after selling out during the quarter.
  • UBS O'Connor sold 30,000 Prothena Corp shares in Q3 2016, an estimated $1.05M.
  • UBS O'Connor first reported a position in Prothena Corp in Q2 2014 and held it in 4 quarters.
  • UBS O'Connor's Prothena Corp position peaked at $2.12M in Q2 2014.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2016.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.